Cargando…
Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma—An Overview
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third highest cause of mortality from cancer, largely because of delays in diagnosis. There is currently no effective therapy for advanced stage HCC, although sorafenib, the standard treatment for HCC, systemic therapy (including...
Autores principales: | D’Agnano, Igea, Berardi, Anna Concetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072503/ https://www.ncbi.nlm.nih.gov/pubmed/31973229 http://dx.doi.org/10.3390/cancers12020261 |
Ejemplares similares
-
RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines
por: Berardocco, Martina, et al.
Publicado: (2017) -
Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application
por: Marei, Hany E., et al.
Publicado: (2022) -
Signaling by exosomal microRNAs in cancer
por: Falcone, Germana, et al.
Publicado: (2015) -
Astrocytes-Derived Small Extracellular Vesicles Hinder Glioma Growth
por: Serpe, Carmela, et al.
Publicado: (2022) -
Exosomes and Extracellular Vesicles as Emerging Theranostic Platforms in Cancer Research
por: Ailuno, Giorgia, et al.
Publicado: (2020)